MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
5.35
-0.03 (-0.56%)
At close: Nov 28, 2025, 1:00 PM EST
5.31
-0.04 (-0.75%)
After-hours: Nov 28, 2025, 4:29 PM EST
MannKind Employees
As of December 31, 2024, MannKind had 407 total employees, including 403 full-time and 4 part-time employees. The number of employees decreased by 7 or -1.69% compared to the previous year.
Employees
407
Change (1Y)
-7
Growth (1Y)
-1.69%
Revenue / Employee
$770,975
Profits / Employee
$71,826
Market Cap
1.64B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 407 | -7 | -1.69% |
| Dec 31, 2023 | 414 | 19 | 4.81% |
| Dec 31, 2022 | 395 | 46 | 13.18% |
| Dec 31, 2021 | 349 | 108 | 44.81% |
| Dec 31, 2020 | 241 | 8 | 3.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MNKD News
- 17 days ago - MannKind to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 18 days ago - MannKind Corporation (MNKD) Discusses Discontinuation of ICoN-1 Phase III Trial for Nebulized Clofazimine in NTM Lung Disease Transcript - Seeking Alpha
- 19 days ago - MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease - GlobeNewsWire
- 23 days ago - MannKind Commemorates Alfred E. Mann's 100th Birthday with New Scholarship Program Supporting Young Adults Living with Diabetes - GlobeNewsWire
- 23 days ago - MannKind Corporation (MNKD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - MannKind Corporation Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - MannKind Corporation to Hold 2025 Third Quarter Financial Results Conference Call on November 5, 2025 - GlobeNewsWire
- 6 weeks ago - MannKind: Durable Cash Engine, Optional Catalysts Pending - Seeking Alpha